The successful trials come after Starlink rival AST SpaceMobile also used its newly launched satellites to power a video call ...

Fintel reports that on February 24, 2025, JP Morgan upgraded their outlook for bluebird bio (NasdaqGS:BLUE) from Underweight ...

Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.

12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Bluebird Bio (BLUE) to $5 from $40 and keeps an Equal Weight rating on the ...

JPMorgan upgraded Bluebird Bio (BLUE) to Neutral from Underweight without a price target after the company entered into a definitive agreement ...

Verizon and AST have yet again pushed the boundaries of what can be done with mobile devices by successfully trialing a live ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...

Bluebird is the 'brainchild' of locals Andy Daintree and Ian Scott - also known as Scottie. They felt Wedmore needed a community café and a place to showcase South West music talent and the bar has ...

AST SpaceMobile (NASDAQ: ASTS), a producer of low earth orbit (LEO) satellites for cellular networks, saw its stock soar more ...

D&D London has announced plans to rebrand as the Evolv Collection in April. It comes after the restaurant group was sold to ...